Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Top Cited Papers
Open Access
- 9 September 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Applied Microbiology and Biotechnology
- Vol. 92 (3), 479-497
- https://doi.org/10.1007/s00253-011-3557-z
Abstract
DNA gyrase is a type II topoisomerase that can introduce negative supercoils into DNA at the expense of ATP hydrolysis. It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials. The fluoroquinolones are examples of very successful gyrase-targeted drugs, but the rise in bacterial resistance to these agents means that we not only need to seek new compounds, but also new modes of inhibition of this enzyme. We review known gyrase-specific drugs and toxins and assess the prospects for developing new antibacterials targeted to this enzyme.Keywords
This publication has 182 references indexed in Scilit:
- Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase InhibitorsOnline Journal of Public Health Informatics, 2010
- How antibiotics kill bacteria: from targets to networksNature Reviews Microbiology, 2010
- A Conserved Mode of Protein Recognition and Binding in a ParD−ParE Toxin−Antitoxin ComplexBiochemistry, 2010
- Effects of magnesium and related divalent metal ions in topoisomerase structure and functionNucleic Acids Research, 2009
- Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damageNucleic Acids Research, 2008
- YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyraseNucleic Acids Research, 2008
- Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coliMolecular Systems Biology, 2007
- Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-bindingNucleic Acids Research, 2006
- A strand-passage conformation of DNA gyrase is required to allow the bacterial toxin, CcdB, to access its binding siteNucleic Acids Research, 2006
- Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damageNucleic Acids Research, 2006